Partnerships

The WHO/IUIS Allergen Nomenclature Sub-Committee is responsible for maintaining and developing a unique, unambiguous and systematic nomenclature for allergenic proteins. The nomenclature is based on the Linnean system and is applied to all allergens. The primary goal of a systematic nomenclature is to define a common language for scientists. As such, assessment of new allergen candidates for inclusion into this database does not involve a judgement on their clinical significance.  A minimal criterion of demonstrated IgE binding to the suggested allergen using sera from patients allergic to the specific source is required.

Hundreds of millions of people in the world suffer from allergies, and it is estimated that 300 million have asthma. Inadequate or improper diagnosis and treatment of these chronic diseases and of immunodeficiency disorders results in lost productivity and substantial medical and socioeconomic burdens throughout the world.

Recognizing a lack of consensus-driven information and general recommendations, four of the most influential allergy/immunology professional organizations have joined forces to launch the International Collaboration in Asthma, Allergy and Immunology (iCAALL).

EAACI joined the Alliance for Biomedical Research in Europe in March 2014 and attended the most recent General Assembly in Brussels on 11 April 2014.

EAACI became a member of the European Chronic Disease Alliance (ECDA) in February 2014 and attended the first EU Summit on Chronic Diseases from 3 – 4 April.

EAACI became eligible to be involved in the European Medical Agency’s (EMA) activities in April 2014 and was added to the list of healthcare professional’s organisations which is published on the agency’s website.

touchRESPIRATORY.com is an independent information resource supporting physicians, clinicians and leading industry professionals in continuously developing their knowledge, effectiveness and productivity, via free-to-access content in multimedia formats.